Lv3
229 积分 2021-05-10 加入
“Cytokine Storm” in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improve PreClinical Testing of Immunotherapeutics
26天前
已完结
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
1个月前
已完结
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
1个月前
已完结
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
2个月前
已完结
Soluble levels of 4‐1BB (CD137) and OX40 (CD134) are associated with cancer progression in gastric adenocarcinoma
3个月前
已完结
An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-β with enhanced antitumor efficacies
4个月前
已完结
PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer
4个月前
已完结
Immune cell densities, HLA status, and PD-L1 expression in stage I neuroendocrine neoplasm of the uterine cervix
6个月前
已完结
Analysis of immune landscape in pancreatic and ileal neuroendocrine tumours demonstrates an immune cold tumour microenvironment
6个月前
已完结
Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade
8个月前
已完结
皖公网安备34019202002308
